Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Patients may experience tenderness, slight swelling, or redness at the injection sites, but these effects are temporary and will subside on their own within a day
Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono
This reflects the fulfillment process since 503B pharmacies do not ship directly to patients, a partner pharmacy is involved to facilitate dispensing and delivery
Both receptor systems also recruit -arrestin and undergo internalization with kinetics that depend on the specific agonist and tissue context
Personalized Nutritional Recommendations: You get personalized recommendations for amino acids, fatty acids, vitamins, minerals, and digestive support
US$ 21.12
US$ 23.08
US$ 21.31
US$ 29.19
US$ 28.30
US$ 21.35
US$ 20.43
US$ 21.35
US$ 24.94